Objective: To explore the therapeutic role and mechanism of exosomes obtained from the supernatant of stem cells derived from human exfoliated deciduous teeth (SHED-exos) in sialadenitis caused by Sjögren syndrome (SS).Methods: SHED-exos were administered to the submandibular glands (SMGs) of 14-week-old nonobese diabetic (NOD) mice, an animal model of the clinical phase of SS, by local injection or intraductal infusion. The saliva flow rate was measured after pilocarpine intraperitoneal injection in 21-week-old NOD mice. Protein expression was examined by Western blot analysis. Exosomal miRNAs were identified by microarray analysis. Paracellular permeability was evaluated by transepithelial electrical resistance measurement.Results: Local injection of SHED-exos significantly increased saliva secretion and alleviated lymphocytic infiltration in the SMGs of NOD mice. The injected SHED-exos could be taken up by glandular epithelial cells and increased ZO-1 expression. Moreover, SHED-exos increased paracellular permeability, whereas this effect disappeared in ZO-1 knockout cells and reappeared in ZO-1-rescued cells. Furthermore, 180 exosomal miRNAs were identified from SHED-exos, and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis suggested that the PI3K/Akt pathway might play an important role. SHED-exos treatment induced the downregulation of p-Akt/Akt, p-GSK-3β/GSK-3β, and Slug and the upregulation of ZO-1 in SMGs and SMG-C6 cells. Both the increased ZO-1 expression and paracellular permeability induced by SHED-exos were abolished by IGF1, a PI3K agonist. In addition, Slug bound to the ZO-1 promoter and suppressed its expression. For safer and more effective clinical application, SHED-exos were intraductally infused into the SMGs of NOD mice, and saliva secretion was increased and accompanied by decreased levels of p-Akt/Akt, p-GSK-3β/GSK-3β, and Slug and increased ZO-1 expression.Conclusion: Local application of SHED-exos in SMGs can ameliorate Sjögren syndrome-induced hyposalivation by increasing the paracellular permeability of glandular epithelial cells through Akt/GSK-3β/Slug pathway-mediated ZO-1 expression.